Dual-modality imaging demonstrates the enhanced antitumoral effect of herpes simplex virus-thymidine kinase/ganciclovir plus gemcitabine combination therapy on cholangiocarcinoma.
about
Dual-modality imaging demonstrates the enhanced antitumoral effect of herpes simplex virus-thymidine kinase/ganciclovir plus gemcitabine combination therapy on cholangiocarcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dual-modality imaging demonstr ...... therapy on cholangiocarcinoma.
@en
Dual-modality imaging demonstr ...... therapy on cholangiocarcinoma.
@nl
type
label
Dual-modality imaging demonstr ...... therapy on cholangiocarcinoma.
@en
Dual-modality imaging demonstr ...... therapy on cholangiocarcinoma.
@nl
prefLabel
Dual-modality imaging demonstr ...... therapy on cholangiocarcinoma.
@en
Dual-modality imaging demonstr ...... therapy on cholangiocarcinoma.
@nl
P2093
P2860
P356
P1476
Dual-modality imaging demonstr ...... therapy on cholangiocarcinoma.
@en
P2093
P2860
P304
P356
10.3892/ETM.2016.3294
P577
2016-04-26T00:00:00Z